1. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE: Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801–806.
2. Muller JE, Stone PH, Turi ZG, et al: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315–1322.
3. Kario K, Pickering TG, Umeda Y, et al: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401–1406.
4. Ohkubo T, Asayama K, Kikuya M, et al: Prediction of ischaemic and haemorrhagic stroke by self-measured blood pressure at home: the Ohasama study. Blood Press Monit 2004; 9: 315–320.
5. Ohkubo T, Imai Y, Tsuji I, et al: Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a populationbased observation in Ohasama, Japan. J Hypertens 1998; 16: 971–975.
6. Imai Y, Hozawa A, Ohkubo T, et al: Predictive values of automated blood pressure measurement: what can we learn from the Japanese population⎯the Ohasama study. Blood Press Monit 2001; 6: 335–339.
7. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O: Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care 2002; 25: 2218–2223.
8. Tamaki S, Ohnishi M, Morimoto S, Horie M: Antihypertensive Therapy of Morning Blood Pressure⎯ATOM Study⎯. Jpn Pharmacol Ther 2004; 32: 481–486 (in Japanese).
9. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension: Guidelines for the Management of Hypertension (JSH 2004). Tokyo, Life Science Publication, 2004, 132 pp (in Japanese).
10. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, San Antonio Heart Study: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153–3159.
11. Sattar N, Gaw A, Scherbakova O, et al: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414– 419.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
13. Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
14. The Examination Committee of Criteria for Metabolic Syndrome: Definition and criteria of metabolic syndrome. J Jpn Soc Int Med 2005; 94: 794–809 (in Japanese).
15. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Available from: http://www.idf.org/home/index.cfm?unode=1120071 E-AACE-41D2-9FA0-BAB6E25BA072
16. Hozawa A, Ohkubo T, Nagai K, et al: Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch Intern Med 2000; 160: 3301–3306.
17. Ohkubo T, Obara T, Funahashi J, et al, J-HOME Study Group: Control of blood pressure as measured at home and office, and comparison with physicians’ assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27: 755–763.
18. Sironi AM, Gastaldelli A, Mari A, et al: Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004; 44: 127–133.
19. Alvarez GE, Beske SD, Ballard TP, Davy KP: Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533–2536.
20. Ebata H, Hojo Y, Ikeda U, Ishida H, Natsume T, Shimada K: Differential effects of an alpha 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 1995; 18: 125–130.
21. Nakazato T, Shikama T, Toma S, Nakajima Y, Masuda Y: Nocturnal variation in human sympathetic baroreflex sensitivity. J Auton Nerv Syst 1998; 70: 32–37.
22. Grassi G, Dell’Oro R, Quarti-Trevano F, et al: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48: 2689–2690.
23. Panza JA, Epstein SE, Quyyumi AA: Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325: 986–990.
24. Wofford MR, Anderson DC Jr, Brown CA, Jones DW, Miller ME, Hall JE: Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 2001; 14: 694–698.
25. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program−Adult Treatment Panel III to Japanese men⎯the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203–208.
26. Tanaka H, Shimabukuro T, Shimabukuro M: High prevalence of metabolic syndrome among men in Okinawa. J Atheroscler Throm 2005; 12: 284–288.
27. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
28. Imai Y, Munakata M, Tsuji I, et al: Seasonal variation in blood pressure in normotensive women studied by home measurements. Clin Sci 1996; 90: 55–60.